One of the striking differences between penicillin and streptomycin is the rapid ty with which microorganisms develop resistance to the latter. Resistance to penicillin can be acquired, but always in relatively small increments at each subcultivation on artificial media or in each passage of the strain through an experimental animal. A high degree of resistance can be attained in vitro or -in vivo only by repeated exposure to increasing concentrations of the drug.
One of the striking differences between penicillin and streptomycin is the rapid ty with which microorganisms develop resistance to the latter. Resistance to penicillin can be acquired, but always in relatively small increments at each subcultivation on artificial media or in each passage of the strain through an experimental animal. A high degree of resistance can be attained in vitro or -in vivo only by repeated exposure to increasing concentrations of the drug. Miller and Bohnhoff (1947a) , for instance, found that 147 transfers onto media containing increasing concentrations of penicillin raised the resistance of a strain of meningococcus sufficiently to permit it to grow abundantly on media containing 5,000 units per ml. They have also shown Bohnhoff, 1946b, 1947b) that the resistance of a strain of meningococcus could be increased by serial passage through m ce treated with subcurative doses of penicillin. They used cultures of hearts' blood as inocula for each succeeding animal passage. The dose required to protect approximately half of the mice rose from 10 units to 1,700 units in the course of 61 passage inoculations.
Resistance to streptomycin, on the other hand, was found to develop with such rapidity that two or three transfers onto media containing increasing concentrations sufficed to permit meningococcus or gonococcus to multiply on media containing 50,000 lig of streptomycin per ml (Miller and Bohnhoff, 1946a) . Meningococci which were rendered streptomycin-resistant by this means retained approximately the virulence of the original parent culture and were resistant to streptomycin in vivo. Mice inoculated with such resistant meningococci died in spite of doses of streptomycin which would have protected them against infection with normal meningococci.
The present communication presents evidence that this rapid development of streptomycin resistance by meningococcus is due to the selective propagation of resistant variants which become apparent during growth on streptomycincontaining media. These variants are presumed to originate from streptomycinresistant mutants which are arising regularly in the bacterial population of the normal parent strain before its exposure to the drug. In the course of these experiments, a second variant has been encountered which is not only resistant to streptomycin but is actually dependent on streptomycin for its growth (Miller and Bohnhoff, 1947a) . Several other media were employed at various times for purposes of comparison and to make certain that the results obtained were not dependent on any ingredient of the medium itself. Media thus employed were meat digest cysteine agar (Miller and Bohnhoff, 1947a) , Difco nutrient agar, brain heart infusion agar, and proteose peptone no. 3 agar.
The media were usually enriched by the addition of fresh, defibrinated sheep or rabbit blood. A few experiments were conducted with agar containing rabbit serum.
When a liquid medium was required trypticase soy broth3 was used. Preparation of streptomycin media. A total of 25 preparations of streptomycin4 have been used. They were obtained from seven manufacturers and varied widely in streptomycin activity but included some preparations of an especially high degree of purity.
Plates of streptomycin agar were made up as follows and were always used within a few hours of preparation: a saline solution of streptomycin was diluted to convenient concentrations and 1 ml of appropriate dilutions pipetted into each petri dish. Five-tenths ml of fresh, defibrinated blood were then put beside it. Melted agar (cooled to 45 C) was added, and the contents of each plate were thoroughly mixed.
Method of inocution of the streptomycin plates. When heavy seedings of meningococci were to be planted onto a series of plates containing graded concentrations of streptomycin, the following technique was employed because it STREPTOMYCIN-RESISTANT MENINGOCOCCUS are customarily used for defibrinating blood, were placed on the surface of the agar in each plate. It was found to be convenient to have these "beads" distributed in test tubes, 5 to a tube, before sterilization, so that the whole contents of a tube could be rolled out gently onto the agar surface.
The 18-hour growth from an agar culture in an ordinary 16-ounce medicine bottle was harvested in 9.0 ml of gelatin Locke's solution,5 sedimented by centrifugation, and resuspended in 0.5 ml gelatin Locke's solution. The meningococci were dispersed by drawing the suspension repeatedly into a capillary pipette from which one drop was allowed to fall onto the agar in each plate. These inocula contained approximately 1.0 to 2 X 10'°microorganisms. The plates were then stacked in a holder and shaken gently in all directions so that the beads rolled back and forth over the surface of the agar and distributed the inocula uniformly. The beads were then discarded. The plates were incubated for 3 days, the first in a candle jar, and then allowed to stand for a few more days at room temperature. They were all examined carefully each day for 5 or 6 days.
Mouse inoculations were made to determine virulence and also streptomycin resistance. A loopful of growth from an 18-hour culture was rubbed up in a few ml of gelatin Locke's solution and the suspension diluted until it reached a density equal to no. 3 of the McFarland series (Kolmer and Boerner, 1945) , Nvhich experience has shown to contain approximately one billion meningococci per ml. From this standard suspension, 10-fold dilutions were made in 4 per cent mucin6 and 1 ml quantities injected intraperitoneally into mice weighing 16 to 20 grams (Miller and Castles, 1936) .
Mice were treated with streptomycin by the injection of the desired dose in 0.5 ml of saline under the skin of the animal's back.
As many as possible of the mice that died were autopsied, and cultures of hearts' blood were made on casein digest agar and also on the same agar to which 100 ,ug of streptomycin per ml had been added.
EXPERIMENTAL RESULTS
The two variants described below appeared wvhen meningococci were inoculated onto media containing streptomycin greatly in excess of that which is considered the optimal bactericidal concentration. Identical results were obtained from cultures started with a single isolated colony and from an ordinary transfer of a stock culture. A heavy seeding of an overnight growth of a normal, sensitive strain of meningococcus was planted onto a series of 8 to 12 plates containing graded concentrations of streptomycin. As most of the experiments were performed with one preparation of streptomycin,7 the concentrations given below are those of that single preparation. The range varied from 10 ,ug per ml to 10,000 ,ug per ml. The intermediate concentrations were usually 20, 40, 60, 100, 200, 400, 600, 1,000, and 4,000 ,ug per ml.
The growth on a series of 6 plates is shown in figure 1 . After 24 hours' incubation, the plate containing 10 Ag per ml showed confluent growth, and the one containing 20 Ag per ml a very large number of colonies indistinguishable from normal meningococcus colonies. A few of these normal colonies occasionally appeared on 40 ,g per ml, but none on concentrations higher than that.
Type A variant. On plates containing 40 Ag per ml, a second type of colony was visible at the end of 24 hours' incubation and continued to grow for the next 48 hours, reaching a size of 3 to 5 mm in diameter; i.e., considerably larger than normal meningococcus colonies. It differed from normal colonies in color as well as size, for it acquired a distinctly yellowish tinge which became more marked during the second and third day of incubation and after another day or two at room temperature. This variant, which developed from each of the 18 strains, has been designated type A.
Except on plates containing 10 to 20 ,g per ml which were so crowded with normal colonies that they could not be distinguished, type A variants developed in about equal numbers from any given strain on all concentrations of the drug. This number, however, varied from strain to strain. Most strains produced 2 to 5 colonies per plate, an average incidence of approximately 1 to 3 in 1010 of original bacterial population. Figure 2 presents the results of 32 experiments performed with one strain (113) and illustrates the uniformity of incidence of type A colonies. One strain, however, developed greater numbers of type A colonies, 5 to 30 per plate.
The type A variants had the following properties: They were highly resistant to streptomycin as they were able to grow on concentrations of the drug as high as 10,000 ,ug per ml. They were also able to multiply on streptomycin-free media. They retained all of the following properties of the parent strains from which they arose: morphology, staining characteristics, sugar fermentation, virulence for mice, and type specificity as deterinined by agglutination and by mouse protection tests. Their streptomycin resistance was demonstrated in vivo by inoculating mice with mucin suspensions and treating the animals with 15,000 ,ug in 3 subcutaneous injections of 5,000 ,ug each at 1, 3, and 5 hours after inoculation. The mice regularly died of meningococcal sepsis, and type A variants were cultured from their hearts' blood.
No loss of streptomycin resistance has been detected in the type A variants either during passage through mice or during subcultivation on streptomycinfree media. Two strains have been transplanted every 5 to 7 days for one year.
Type A variants were found to be slightly more sensitive to penicillin than the parent strain from which they arose. figure 3 , w<hich shows (a) that the actual numbers varied considerably in different experiments and (b) that they were always most numerous between concentrations of 100 and 400 ,ug per ml. Curves of the numbers of colonies in individual experiments differed in height but almost alw-ays had the shape of the curve of the mean show+n in figure 3 .
The meningococci composing these type B colonies had the following properties: They were resistant to streptomycin, for they were able to grow on concentrations as high as 5,000 ,ug per ml. They were dependent on streptomycin for growth; that is, they would grow abundantly from small inocula on concentrations between 100 and 400 Ag per ml and would also grow from large inocula on concentrations as low as 5 ,ug per ml, but they could not be subcultured on media containing less than that minimum of streptomvcin. They w-ere nonvirulent for mice unless the mice were treated with streptomvcin as described below. They were gram-negative and fermented glucose andl maltose when the test media contained 100 ,g of streptomycin per ml. They retained the tyrpe specificity of the parent strain from wN-hich they arose. Rabbit sera prepared against the parent strain conferred protection against experimental infection with these variants in mice treated with streptomv-cin.
MIicroscopically, the type B organisms varied somew-hat with the concentrations of streptomycin on which they had developed. Preparations made from the small grayl colonies grow-n on 60 or 100 ,ug per ml showed them to be slightly larger than normal meningococci. Ty-pe B organisms growing on higher concentrations in larger pigmented colonies were indistinguishable from normal meningococci. This difference may well be related to the stimulating action of streptomycin mentioned below.
Althouigh the colonial development and microscopic appearance of type B variants differed according to the concentration of streptomvcin on which they grew, the identity of all members of this variant w0-as indicated by the followl-ing The dependence of type B variants on adequate concentrations of streptomycin for growth was also demonstrated by subculturing them into broth containing graded concentrations of the drug (see figure 4 ). It will be seen that no growth occurred in the broth containing the low and high concentrations of streptomycin. The optimum range for multiplication in liquid media, therefore, approximated that for solid media.
When a series of plates containing graded concentrations of streptomycin was planted with a pure culture of the B variant in small but equal inocula, the numbers of colonies which developed bore exactly the same relationship to 1947] 473 When type B colonies were tested for their sensitivity to penicillin, their growth was inhibited by approximately the same concentrations that inhibited the growth of the normal parent strain from which each variant arose. They appeared, therefore, to be as sensitive as normal meningococci to penicillin. It should be pointed out, however, that the tests could not be made on the same media because of the necessity of providing sufficient streptomycin for the development of type B variants in amounts which were bacteriostatic for the normal strain.
Reversion of type B variants. The type B variants continued to exhibit all the characteristics described during repeated subcultivation on streptomycin agar. Their dependence on the drug has been complete except for four instances in which a single colony has developed on streptomycin-free agar. The four exceptions were the only ones to occur among many subcultivations onto streptomycin-free agar. In each instance the colony grew out slowly, but thereafter multiplied readily on streptomycin-free media. They retained all of the properties of meningococci and are regarded as mutations back toward normal. Their reversion to normal was not quite complete, however, for three of them developed no type B variants when planted onto graded concentrations of streptomycin, but only type A. The other reverted strain was able to develop both type A and type B colonies, but the numbers of the former were greater than those produced by its original parent strain. It is clear, therefore, that none of these reverted mutants had regained all of the potentialities of the parent strain from which they were originally derived.
Effect of inactivated streptomycin. The type B variants were unable to grow on media containing streptomycin inactivated by hydroxylamine hydrochloride according to the method of Donovick, Rake, and Fried (1946) or by cysteine hydrochloride according to the method of Denkelwater, Cook, and Tishler (1945) .
Experimental infection with type B variants. The dependence of the type B variants on streptomycin for their multiplication could be demonstrated in vivo as well as in vitro. When mice were inoculated with mucin suspensions of type B variants, the mice usually survived unless they were treated with streptomycin. An occasional mouse died if very large inocula were used, but meningococci were rarely recovered from its hirt's blood, and then only on streptomycin-containing agar.
On the other hand, mice treated with adequate doses of streptomycin usually succumbed to meningococcal sepsis, and type B variants were regularly recovered from cultures of their hearts' blood on streptomycin-containing agar. Although hearts' blood was always planted onto streptomycin-containing and streptomycin-free media, no meningococci ever grew out on the latter.
In variants; that is, they retained their type specificity and their ability to ferment glucose and maltose but required streptomycin for growth.
Unusually large inocula were used in the experiment just described. It has not as yet been possible, however, to produce fatal meningococcal sepsis regularly in mice with inocula smaller than 104 meningococci even though the animals received multiple injections of streptomycin. The virulence of the type B variants appears, therefore, to be less than that of the type A variants.
DISCUSSION
In these experiments two variants have arisen from cultures of meningococcus planted in heavy seedings onto a series of plates containing graded concentrations of streptomycin. It should be emphasized that each experiment was begun with a culture which had never been exposed to streptomycin and that inoculation onto the various concentrations of streptomycin was made at one time. Both variants developed from all of the 18 strains of meningococcus studied. They were gram-negative diplococci which retained the characteristic sugar fermentation and type specificity of the parent strains from which they arose. Both variants were highly resistant to streptomycin.
One variant, designated type A, grew in large, yellowish colonies which appeared in approximately equal numbers on all concentrations of the drug although the numbers varied considerably from strain to strain. Its resistance to streptomycin was demonstrated in vivo as well as in vitro, for it produced infection in mice which proved uniformly fatal in spite of the administration of maximal doses of streptomycin tolerated by the mice.
The incidence of the other variant, designated type B, as well as the size and color of its colonies depended on the concentrations of streptomycin onto which the original seedings were planted. Nevertheless, all of the B variants derived from any strain were found to be genetically alike.
The striking characteristic of this variant was its dependence on streptomvcin for multiplication on solid and in liquid media and in the body of an animal host. The animal experiments indicated that this variant was nonvirulent for mice unless the animals were treated with adequate doses of streptomycin and that the dependence on streptomycin for growth persisted during and after multiplication within the body of the infected animal.
It is impossible at the present time to be certain whether the substance required for the growth of the type B variant is streptomycin itself or some impurity which has been present in all of the preparations we have used. These numbered 25 and were obtained from seven manufacturers. Two of the preparations were described as being of an especially high degree of purity. It The maximum incidence of the type B variants varied from 2 to 15 per billion meningococci in the parent culture.
When the type B variants were first observed, they were thought to arise by mutation which was induced by streptomycin. Subsequent observations have failed to support this hypothesis and have tended instead to indicate that, like the A variants, they, too, originated from mutations which were occurring regularly in the parent bacterial population.
The fact that they appeared only on the high concentrations and only in greatest numbers within a certain range was explained by the demonstration that this range of concentrations was optimal for their development. Pure cultures of the B variants developed colonies on each concentration of streptomycin in the same relative numbers as did heavy seedings of the parent strain from which they arose. The greater proportion of them were able to reproduce only on certain concentrations; above and below that optimal range few or none developed. In other words, the type B variants developed approximately the same number of colonies on each of a series of concentrations whether they were planted in pure culture or together with myriads of normal, streptomycinsensitive meningococci. This observation seems to indicate that the streptomycin requirement of the type B variants for their multiplication is quantitative as well as qualitative.
The variation in size and color of colony of the B mutants can only be attributed to the direct effect of streptomycin on the physiology of the microorganisms. Benham (1947) found that streptomycin increased the oxygen uptake of a normal strain of typhoid bacilli but not of a resistant one unless high concentrations of the drug were used.
Several studies on the development of streptomycin resistance have appeared: Chandler and Schoenbach (1947) for staphylococcus, streptococcus, and pneumococcus; Hamre, Rake, and Donovick (1946) for Klebsiella; and Kimmelman (1946a, 1946b) . Alexander and Leidy (1947) , using a technique similar to ours, isolated streptomycin-resistant variants from Hemophilus influenzae and estimated their incidence as 1 in 1.1 billion to 1 in 13.8 billion members of the original bacterial population. As none of these authors mentions dependence on streptomycin as a characteristic of the resistant strains, one must conclude that they were dealing with resistant variants analogous to the type A variants herein described. It is quite certain that the streptomycin-resistant gonococci and meningococci reported earlier by Miller and Bohnhoff (1946a) were type A variants. Hall and Spink (1947) After it had become highly resistant, it produced two types of colonies, a large one, which grew rapidly, and a small one, which grew slowly. Although this latter variant was able to grow on streptomycinfree agar, it grew better on media containing 50 to 100 ,ug of streptomycin per ml. It is possible that this second type of colony is similar to our B variant.
It should be noted that Welch, Price, and Randall (1946) were able to demonstrate large numbers of viable typhoid bacilli in broth cultures containing streptomycin in concentrations greater than the minimum which inhibited growth. They also found that the mortality rate of mice infected with typhoid bacilli was increased by treatment with small doses of streptomycin (0.05 to 1.0 ,ug). The mortality rate, however, was decreased when larger doses were administered.
For a comprehensive discussion of the general problem of bacterial mutation, the reader is referred to the recent review by Luria (1947) .
Studies on the growth requirements of mutants isolated from cultures of Escherichia coli after treatment with bacteriophage (Anderson, 1944; Luria and Delbruck, 1943; Luria, 1945) or X-ray (Tatum, 1945; Gray and Tatum, 1944) have demonstrated a variety of deficiencies in their metabolic processes. Similar observations have been made on mutants induced in Neurospora by X-ray (Beadle, 1945) .
Emerson (1944) has described a mutant of Neurospora which required sulfanilamide for growth and for which para-aminobenzoic acid was toxic. This variant appeared in his cultures only once.8 The type B variants of meningococcus, on the other hand, developed regularly from all of 18 strains which included types I, II, and II alpha, some of which strains had recently been isolated from cases of epidemic meningitis and some from carriers, but others were old stock trais which had been under cultivation in the laboratory for many years 480 C. PHILLIP MILLER AND MARJORIE BOHNHOFF [VOL. 64 multiplication. Its colonies varied in size and color depending upon the concentrations of streptomycin on which they developed. They were small and gray on concentrations of less than 100 ,ug per ml and larger and slightly yellowish on concentrations of 200 ,ug or more per ml. Nevertheless, the type B variants from any strain were found to be genetically identical and the differences in their colonial appearance to be determined by the concentration of streptomyci on which they grew.
The type B variants were dependent on streptomycin for multiplication in vitro and in vivo. They were nonviable on media containing concentrations of less than 5 ,ug per ml and grew best on 100 to 400 ,ug per ml. They were nonvirulent for mice, unless the mice received streptomycin. In mice treated with streptomycin, they produced a fatal meningococcal sepsis and were recovered from the hearts' blood provided the cultures were made on streptomycincontaining media.
Both variants retained the characteristic sugar fermentations of meningococci and the type specificity of the parent strains from which they arose. Both variants are presumed to arise from mutants which are constantly appearing in the bacterial population of the parent strain.
Whether the substance required by the B variants for their multiplication is streptomycin itself or some impurity has not yet been determined. These variants developed on all of 25 preparations of streptomycin obtained from 7 manufacturers. They failed to develop on streptomycin inactivated by hydroxylamine or by cysteine.
